Is the Malononitrilamide FK778 Better for the Prevention of Acute or Chronic Rejection?
Deuse T, Schrepfer S, Pelletier M, Fischbein M, Robbins R, Reichenspurner H. Is the Malononitrilamide FK778 Better for the Prevention of Acute or Chronic Rejection? Transplantation Proceedings 2007, 39: 569-572. PMID: 17362784, DOI: 10.1016/j.transproceed.2006.12.020.Peer-Reviewed Original ResearchConceptsObliterative airway diseaseUntreated recipientsLuminal obliterationComplete luminal obliterationEfficacy of FK778Rat cardiac transplantsTracheal luminal obliterationCardiac allograft survivalProlonged graft survivalChronic allograft rejectionAcute heart rejectionMalononitrilamide FK778Mycophenolate mofetilAllograft survivalChronic rejectionCardiac transplantationImmunosuppressive agentsAllograft rejectionGraft survivalFK778Heart rejectionAirway diseaseTacrolimusTracheal transplantationIntense infiltration
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply